B, M., SA, G., AE, A., & SS, E. (2024). Telmisartan ameliorates nephropathy and restores the hippo pathway in rats with metabolic syndrome. European journal of pharmacology, 973, 176605. https://doi.org/10.1016/j.ejphar.2024.176605
Chicago Style (17th ed.) CitationB, Mohamed, Ghareib SA, Alsemeh AE, and El-Sayed SS. "Telmisartan Ameliorates Nephropathy and Restores the Hippo Pathway in Rats with Metabolic Syndrome." European Journal of Pharmacology 973 (2024): 176605. https://doi.org/10.1016/j.ejphar.2024.176605.
MLA (9th ed.) CitationB, Mohamed, et al. "Telmisartan Ameliorates Nephropathy and Restores the Hippo Pathway in Rats with Metabolic Syndrome." European Journal of Pharmacology, vol. 973, 2024, p. 176605, https://doi.org/10.1016/j.ejphar.2024.176605.